Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder

Neuropsychopharmacology

Volumn 29, Issue 3, 2004, Pages 558-565

  Hamilton, Steven P ^a,e   Slager, Susan L ^b   De Leon, Ada Baisre ^a   Heiman, Gary A ^c   Klein, Donald F ^a   Hodge, Susan E ^a,d   Weissman, Myrna M ^a,c   Fyer, Abby J ^a   Knowles, James A ^a,f  

^a Columbia University ^*  (United States)

^b MAYO CLINIC   (United States)

^c Division of Biostatistics ^*  (United States)

^d Section of Biostatistics   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Adenosine receptor; ADORA2A; Association; Genetic; Linkage; Panic disorder; SNP

Indexed keywords

ADENOSINE 2A RECEPTOR; ADENOSINE RECEPTOR; UNCLASSIFIED DRUG;

AGORAPHOBIA; ARTICLE; CHROMOSOME 22; DNA SEQUENCE; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PANIC; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; PANIC DISORDER; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ADENOSINE A2A;

EID: 1642308532     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300311     Document Type: Article

References (55)

1. Abecasis GR, Cookson WO (2000). GOLD - graphical overview of linkage disequilibrium. Bioinformatics 16: 182-183.
2. Abreu PC, Greenberg DA, Hodge SE (1999). Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am J Hum Genet 65: 847-857.
3. Adams P (1994). LABMAN and LINKMAN: a data management system specifically designed for genome searches of complex diseases. Genet Epidemiol 11: 87-98.
4. Alsene K, Deckert J, Sand P, De Wit H (2003). Association between A(2a) receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, (advance online publication, 25 June 2003; doi:10.1038/sj.npp.1300232) 28: 1694-1702.
5. Carlini DB, Stephan W (2003). In vivo introduction of unpreferred synonymous codons into the Drosophila Adh gene results in reduced levels of ADH protein. Genetics 163: 239-243.
6. Charney DS, Heninger GR, Jatlow PI (1985). Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42: 233-243.
7. Chen X, Levine L, Kwok PY (1999). Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 9: 492-498.
8. Clayton D (1999). A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65: 1170-1177.
9. Clayton DG (1998). TRANSMIT [v2.3].
10. Conticello SG, Pilpel Y, Glusman G, Fainzilber M (2000). Position-specific codon conservation in hypervariable gene families. Trends Genet 16: 57-59.
11. Cottingham Jr RW, Idury RM, Schaffer AA (1993). Faster sequential genetic linkage computations. Am J Hum Genet 53: 252-263.
12. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M et al (1998). Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3: 81-85.
13. Devlin B, Risch N (1995). A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29: 311-322.
14. Dunwiddie TV, Masino SA (2001). The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55.
15. Durner M, Vieland VJ, Greenberg DA (1999). Further evidence for the increased power of LOD scores compared with nonparametric methods. Am J Hum Genet 64: 281-289.
16. Excoffier L, Slatkin M (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 921-927.
17. Falk CT, Rubinstein P (1987). Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51: 227-233.
18. Fyer AJ, Weissman MM (1999). Genetic linkage study of panic: clinical methodology and description of pedigrees. Am J Med Genet (Neuropsychiatr Genet) 88: 173-181.
19. Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S et al (2001). Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 105: 548-557.
20. Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B et al (2001). A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106: 367-379.
21. Greenberg DA, Abreu P, Hodge SE (1998). The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 63: 870-879.
22. Guieu R, Dussol B, Halimi G, Bechis G, Sampieri F, Berland Y et al (1998). Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen Pharmacol 31: 553-561.
23. Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Hodge SE et al (1999). Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 9: 1-6.
24. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF et al (2002). Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biolog Psychiatry 51: 591-601.
25. Hamilton SP, Slager SL, Helleby L, Heiman GA, Klein DF, Hodge SE et al (2001). No association or linkage between polymorphisms in the genes encoding cholecystokinin and cholecystokinin B receptor and panic disorder. Mol Psychiatry 6: 59-65.
26. Hettema JM, Neale MC, Kendler KS (2001). A review and metaanalysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568-1578.
27. Hodge SE, Abreu PC, Greenberg DA (1997). Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet 60: 217-227.
28. Katschnig H, Amering M (1998). The long-term course of panic disorder and its predictors. J Clin Psychopharmacol 18: 6S-11S.
29. Knowles JA, Fyer AJ, Vieland VJ, Weissman MM, Hodge SE, Heiman GA et al (1998). Results of a genome-wide genetic screen for panic disorder. Am J Med Genet (Neuropsychiatr Genet) 81: 139-147.
30. Knowles JA, Weissman MM (1995). Panic disorder and agoraphobia. In Oldham JM, Riba MB (eds). Review of Psychiatry, Volume 14. American Psychiatric Press: Washington, DC. Vol. 14, pp 383-404.
31. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674-678.
32. Lee MA, Flegel P, Greden JF, Cameron OG (1988). Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 145: 632-635.
33. Lin AS, Uhde TW, Slate SO, McCann UD (1997). Effects of intravenous caffeine administered to healthy males during sleep. Depress Anxiety 5: 21-28.
34. Lindholm E, Zhang J, Hodge SE, Greenberg DA (2003). The accuracy of haplotype inference in nuclear families: error rates for SNPs and microsatellites. (manuscript submitted).
35. Mannuzza S, Fyer AJ, Endicott J, Klein DF (1985). Family Informant Schedule and Criteria. Anxiety Disorders Clinic: New York State Psychiatric Institute.
36. Mannuzza S, Fyer AJ, Klein DF, Endicott J (1986). Schedule for affective disorders and schizophrenia - lifetime version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. J Pschiat Res 20: 317-325.
37. Moreau JL, Huber G (1999). Central adenosine A(2A) receptors: an overview. Brain Res Brain Res Rev 31: 65-82.
38. Nakamura Y, Gojobori T, Ikemura T (2000). Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 28: 292.
39. Nickell PV, Uhde TW (1994). Dose-response effects of intravenous caffeine in normal volunteers. Anxiety 1: 161-168.
40. Ott J (1999). Analysis of Human Genetic Linkage. Johns Hopkins University Press: Baltimore.
41. Rozen S, Skaletsky HJ (1998). Primer3.
42. Schaffer AA, Gupta SK, Shriram K, Cottingham Jr RW (1994). Avoiding recomputation in linkage analysis. Hum Hered 44: 225-237.
43. Schaid DJ, McDonnell SK, Wang L, Cunningham JM, Thibodeau SN (2002). Caution on pedigree haplotype inference with software that assumes linkage equilibrium. Am J Hum Genet 71: 992-995.
44. Sebastiao AM, Ribeiro JA (2000). Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21: 341-346.
45. Smoller JW, Acierno Jr JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S et al (2001). Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet 105: 195-206.
46. Spielman RS, McGinnis RE, Ewens WJ (1993). Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.
47. Tabiner M, Youings S, Dennis N, Baldwin D, Buis C, Mayers A et al (2003). Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines. Am J Hum Genet 72.
48. Terwilliger JD (1994). The available possibilities to analyze data of polygenic disease statistically. Abstract to IVth Workshop of the Nordic Genome Initiative, Helsinki.
49. Terwilliger JD (1995). A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56: 777-787.
50. Terwilliger JD, Ott J (1992). A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 42: 337-346.
51. Vieland VJ, Goodman DW, Chapman T, Fyer AJ (1996). New segregation analysis of panic disorder. Am J Med Genet 67: 147-153.
52. Vieland VJ, Greenberg DA, Hodge SE (1993a). Adequacy of single-locus approximations for linkage analyses of oligogenic traits: extension to multigenerational pedigree structures. Hum Hered 43: 329-336.
53. Vieland VJ, Hodge SE, Lish JD, Adams P, Weissman MM (1993b). Segregation analysis of panic disorder. Psychiatr Genet 3: 63-71.
54. Vieland VJ, Logue M (2002). HLODs, trait models, and ascertainment: implications of admixture for parameter estimation and linkage detection. Hum Hered 53: 23-35.
55. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T (2001). Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108: 837-848.